Becton Dickinson & Co BRDR B1DX34
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- R$186.30
- Day Range
- R$179.82–179.82
- 52-Week Range
- R$139.29–218.46
- Bid/Ask
- R$0.00 / R$0.00
- Shares Outstanding
- 1.36B
- Market Cap
- R$244.90B
- Volume/Avg
- 12 / 64
Key Statistics
- Price/Earnings (Normalized)
- 13.06
- Price/Sales
- 2.39
- Dividend Yield (Trailing)
- 1.72%
- Dividend Yield (Forward)
- 1.70%
- Dividend Payment Schedule
- Jan, Apr, Jul, Oct
- Total Yield
- 6.99%
Company Profile
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Mid Value
- Total Number of Employees
- 72,000
- Website
- https://www.bd.com
Competitors
Valuation
|
Metric
|
B1DX34
|
BAX
|
MDT
|
|---|---|---|---|
Price/Earnings (Normalized) | 13.06 | 11.94 | 15.63 |
Price/Book Value | 1.93 | 2.03 | 2.25 |
Price/Sales | 2.39 | 1.09 | 3.03 |
Price/Cash Flow | 12.81 | 11.33 | 12.70 |
Price/Earnings
B1DX34
BAX
MDT
Financial Strength
|
Metric
|
B1DX34
|
BAX
|
MDT
|
|---|---|---|---|
Quick Ratio | 0.33 | 1.12 | 1.29 |
Current Ratio | 0.87 | 1.95 | 2.07 |
Interest Coverage | 4.15 | −0.81 | 10.12 |
Quick Ratio
B1DX34
BAX
MDT
Profitability
|
Metric
|
B1DX34
|
BAX
|
MDT
|
|---|---|---|---|
Return on Assets (Normalized) | 4.97% | 4.99% | 8.31% |
Return on Equity (Normalized) | 10.63% | 15.42% | 15.59% |
Return on Invested Capital (Normalized) | 7.26% | 7.44% | 10.57% |
Return on Assets
B1DX34
BAX
MDT
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|#C$rB%? | LOCK|Z# | $150B | |||
| Becton Dickinson & Co
BDX
| LOCK|%y | LOCK|Hvqqx | $50B | |||
| ResMed Inc
RMD
| LOCK|dK!&pPX | LOCK|#k!VX | $32B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|#FB%p^ | LOCK|$<t^# | $32B | |||
| Alcon Inc
ALC
| LOCK|R>wDp^ | LOCK|&^lc | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|RY?M>DY | LOCK|FV | $26B | |||
| Solventum Corp
SOLV
| LOCK|ZvJ@SG | LOCK|YF> | $15B | |||
| Baxter International Inc
BAX
| LOCK|C<r | LOCK|fT$Z | $13B | |||
| Repligen Corp
RGEN
| LOCK|Z$<nT%@S | LOCK|QG#c | $11B | |||
| The Cooper Companies Inc
COO
| LOCK|<<s@Dqh | LOCK|?b@P | $10B |
United States